Ajinomoto Co., Inc. (TYO:2802)
5,566.00
-70.00 (-1.24%)
Aug 14, 2026, 3:30 PM JST
Ajinomoto Co. Revenue
Ajinomoto Co. had revenue of 412.11B JPY in the quarter ending June 30, 2026, with 13.21% growth. This brings the company's revenue in the last twelve months to 1.63T, up 6.72% year-over-year. In the fiscal year ending March 31, 2026, Ajinomoto Co. had annual revenue of 1.58T with 3.47% growth.
Revenue (ttm)
1.63T
Revenue Growth
+6.72%
P/S Ratio
3.26
Revenue / Employee
46.91M
Employees
34,787
Market Cap
5.31T
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.58T | 53.16B | 3.47% |
| Mar 31, 2025 | 1.53T | 91.33B | 6.35% |
| Mar 31, 2024 | 1.44T | 80.12B | 5.89% |
| Mar 31, 2023 | 1.36T | 209.75B | 18.25% |
| Mar 31, 2022 | 1.15T | 77.92B | 7.27% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| NH Foods | 1.49T |
| Yamazaki Baking | 1.34T |
| Meiji Holdings | 1.19T |
| Nisshin Seifun Group | 867.32B |
| Nissin Foods Holdings | 805.77B |
| Nichirei | 774.42B |
| Kikkoman | 771.91B |
| Fuji Oil | 770.26B |
Ajinomoto Co. News
- 9 days ago - Ajinomoto Co. Earnings Call Transcript: Q1 2027 - Transcripts
- 9 days ago - Ajinomoto Co. Quarterly report: Q1 2027 - Filings
- 9 days ago - Ajinomoto Co. Slides: Q1 2027 - Filings
- 24 days ago - Ajinomoto weighs price hikes amid cost pressures - Bangkok Post
- 6 weeks ago - Ajinomoto Co. Transcript: Investor update - Transcripts
- 6 weeks ago - Ajinomoto Co. Slides: Investor update - Filings
- 6 weeks ago - Ajinomoto Co. Slides: Investor presentation - Filings
- 7 weeks ago - Syntax Bio, Ajinomoto Health & Nutrition North America, Inc. Collaborate to Evaluate Stem Cell Culture Technologies Using Cellgorithm™ Platform - Business Wire